Amedisys Acquisition Faces Intense Regulatory Review
Company Announcements

Amedisys Acquisition Faces Intense Regulatory Review

Amedisys Inc (AMED) just unveiled an announcement.

The Oregon Health Authority has initiated a detailed review of UnitedHealth Group’s proposed acquisition of Amedisys, with the process expected to take up to 180 days from December 4, 2023. Approval from the OHA is a critical requirement for the transaction to proceed, highlighting the significant regulatory scrutiny such healthcare market deals undergo. This development is a key consideration for stakeholders and investors watching the evolving landscape of the healthcare industry.

See more insights into AMED stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyUnusually active option classes on open November 13th
TheFlyUnitedHealth says ‘will vigorously defend against the DOJ’s overreaching’
TheFlyDOJ, state AGs sue to block UnitedHealth’s acquisition of Amedisys
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App